HPS Pharmacies wish to advise that Arrow Pharma, in consultation with the Therapeutic Goods Administration (TGA), has given notice of a product alert for Valpam® 5mg as follows:
Valpam® 5mg Tablets
The only affected batch is CP218 with an expiry date of January 2021.
This product alert has been initiated following one instance where a single Valpam® 2mg tablet was found in a blister pack of Valpam® 5mg tablets. Arrow Pharma advises consumers and healthcare professionals to visually inspect blisters from the abovementioned batch before dispensing or use. Valpam® 5mg tablets are coloured light yellow and imprinted with ‘DZ 5’ on one side. Valpam® 2mg tablets are white/off-white.
Please inspect your stock and quarantine any affected packets. If no anomalies are found upon visual inspection of the blisters, the medication may continue to be supplied and administered as usual.
If HPS Pharmacies provide imprest management services to your facility, an HPS representative will inspect all stock stored in the designated imprest areas at the earliest opportunity. All affected products will be quarantined for return to the supplier and HPS Pharmacies will arrange for replacement stock as soon as possible. An HPS Pharmacies staff member will contact senior medical and nursing staff if there is an immediate impact to your facility.
Retain this notice in a prominent position, including in other related business units for one month. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please contact your pharmacist at HPS Pharmacies, or Arrow Pharma on 1800 941 148.